Sign in
4

Changes in Ownership

SELLAS Life Sciences Group, Inc. Filed Acc 0001390478-15-000005

President & CEO acquired 3,846 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
SCHWARTZ MARK W. President & CEO 2014-12-31 Other acquisition +3,846 $1.28 $4,923 415,972 D
Derivatives
SCHWARTZ MARK W. President & CEO 2015-01-16 Grant or award · Stock Option (right to buy) +550,000 550,000 D
Loading xslF345X03/primary_doc.xml…